Global Genomics Group
737 North 5th Street
Suite 103
Richmond
Virginia
23219
United States
Website: http://globalgenomicsgroup.com
10 articles about Global Genomics Group
-
Global Genomics Group (G3) Granted Patent for Breakthrough Diagnostic Blood Test for Plaque Detection in the Heart
1/4/2019
Global Genomics Group announced that a patent for its first precision diagnostic biomarker for the detection of plaque buildup in the heart has been granted by the United States Patent and Trademark office
-
Global Genomics Group (G3) Presents Data for the First Time on the Exact Size of Lipoprotein (a) Particles that Cause Plaque Buildup in Coronary Arteries from its GLOBAL Clinical Study Platform
11/13/2018
Data presented at the Annual Scientific Sessions of the American Heart Association in Chicago, IL on November 12, 2018.
-
Global Genomics Group and Datavant Announce Strategic Partnership to Improve Design and Interpretation of Clinical Trials
1/5/2018
Through this partnership, Datavant and G3 will work together to increase the odds of success and pace of drug development through data-driven approaches.
-
Global Genomics Group In Collaboration With Semmelweis University In Budapest, Hungary, Unravel The Heritability Of Adiposity, Paving The Way To New Drug Targets In Obesity And Non-Alcoholic Fatty Liver Disease
9/14/2017
-
Global Genomics Group Announces Breakthrough Diagnostic Blood Test For Plaque Detection In The Heart
3/21/2017
-
Global Genomics Group And GNS Healthcare Report Preliminary Results Of Largest-Ever Study Linking Biomarkers With Coronary Artery Disease
1/8/2016
-
Global Genomics Group Partners With Sanofi To Identify New Signaling Pathways In Atherosclerotic Cardiovascular Diseases
1/5/2016
-
Global Genomics Group Announces Completion Of Enrollment In GLOBAL Study With 7,500 Patients
5/27/2014
-
Global Genomics Group ("G3") Appoints Harry "Chip" Davis, Zetia® Inventor, As Chief Drug Development Officer
5/6/2014
-
Global Genomics Group And Caprion Proteomics To Partner On GLOBAL Study To Identify Cardiovascular Disease Biomarkers And Drug Targets
2/26/2014